» Articles » PMID: 38650918

Research Progress on the Improvement of Cardiovascular Diseases Through the Autonomic Nervous System Regulation of the NLRP3 Inflammasome Pathway

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Cardiovascular disease stands as a leading global cause of mortality. Nucleotide-binding Oligomerization Domain-like Receptor Protein 3 (NLRP3) inflammasome is widely acknowledged as pivotal factor in specific cardiovascular disease progression, such as myocardial infarction, heart failure. Recent investigations underscore a close interconnection between autonomic nervous system (ANS) dysfunction and cardiac inflammation. It has been substantiated that sympathetic nervous system activation and vagus nerve stimulation (VNS) assumes critical roles withinNLRP3 inflammasome pathway regulation, thereby contributing to the amelioration of cardiac injury and enhancement of prognosis in heart diseases. This article reviews the nexus between NLRP3 inflammasome and cardiovascular disorders, elucidating the modulatory functions of the sympathetic and vagus nerves within the ANS with regard to NLRP3 inflammasome. Furthermore, it delves into the potential therapeutic utility of NLRP3 inflammasome to be targeted by VNS. This review serves as a valuable reference for further exploration into the potential mechanisms underlying VNS in the modulation of NLRP3 inflammasome.

Citing Articles

"The Ameliorative Effect of Interleukin-17A Neutralization on Doxorubicin-Induced Cardiotoxicity by Modulating the NF-κB/NLRP3/Caspase-1/IL-1β Signaling Pathway in Rats".

Hassen M, Mousa N, Radwan S, Gabre R Inflammation. 2025; .

PMID: 40064794 DOI: 10.1007/s10753-024-02187-z.


Weight Status, Autonomic Function, and Systemic Inflammation in Children with Obstructive Sleep Apnea.

Chuang H, Huang C, Hsu J, Chuang L, Huang Y, Li H Int J Mol Sci. 2024; 25(16).

PMID: 39201638 PMC: 11354383. DOI: 10.3390/ijms25168951.

References
1.
Xiao H, Li H, Wang J, Zhang J, Shen J, An X . IL-18 cleavage triggers cardiac inflammation and fibrosis upon β-adrenergic insult. Eur Heart J. 2017; 39(1):60-69. DOI: 10.1093/eurheartj/ehx261. View

2.
Banke A, Fosbol E, Ewertz M, Videbaek L, Dahl J, Poulsen M . Long-Term Risk of Heart Failure in Breast Cancer Patients After Adjuvant Chemotherapy With or Without Trastuzumab. JACC Heart Fail. 2019; 7(3):217-224. DOI: 10.1016/j.jchf.2018.09.001. View

3.
Darwesh A, Keshavarz-Bahaghighat H, Jamieson K, Seubert J . Genetic Deletion or Pharmacological Inhibition of Soluble Epoxide Hydrolase Ameliorates Cardiac Ischemia/Reperfusion Injury by Attenuating NLRP3 Inflammasome Activation. Int J Mol Sci. 2019; 20(14). PMC: 6678157. DOI: 10.3390/ijms20143502. View

4.
Zhou W, Chen C, Chen Z, Liu L, Jiang J, Wu Z . NLRP3: A Novel Mediator in Cardiovascular Disease. J Immunol Res. 2018; 2018:5702103. PMC: 5911339. DOI: 10.1155/2018/5702103. View

5.
Sabbah H, Ilsar I, Zaretsky A, Rastogi S, Wang M, Gupta R . Vagus nerve stimulation in experimental heart failure. Heart Fail Rev. 2010; 16(2):171-8. PMC: 3784341. DOI: 10.1007/s10741-010-9209-z. View